Literature DB >> 3343091

Difference in motile behavior between lymphoma variants with different invasive and metastatic capabilities.

H Verschueren1, D Dekegel, P De Baetselier.   

Abstract

The motile behavior of two tumor cell variants of the murine BW 5147 lymphosarcoma line, displaying different metastatic capabilities, was analyzed. When placed on top of a confluent monocellular layer of fibroblastic cells, the nonmetastatic lymphoma cells did not carry out any appreciable translocation or shape modification, whereas the metastatic cells displayed intense pseudopodal activity and performed positional shifts. Both these aspects of cell motility were approached through quantitative assays, demonstrating a highly significant difference between the two variant lines. In addition, the metastatic cells were shown to penetrate underneath the fibroblastic monolayer, whereas the nonmetastatic cells were unable to invade. We suggest that the difference in motile behavior is at the basis of the different invasive potencies of the variants. Since in vitro monolayer invasion assays mimic the extravasation of blood-borne cells, we further speculate that in this particular model system, cell motility is the discriminating property that determines whether disseminated tumor formation will occur after intravenous injection of either cell line.

Entities:  

Mesh:

Year:  1988        PMID: 3343091

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  3 in total

1.  Dual effects of pertussis toxin on in vitro invasive behavior of metastatic lymphoma variants.

Authors:  H Verschueren; D Van Hecke; E Hannecart-Pokorni; D Dekegel; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

Review 2.  The invasive phenotypes.

Authors:  M M Mareel; F M Van Roy; P De Baetselier
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

3.  Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells.

Authors:  K M Thorp; C Southern; N Matthews
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.